P-496 A multicenter phase II study of docetaxel (D)Igemcitabine (G)weekly in advanced non-small cell lung cancer (NSCLC) in elderly and/or poor performance status (PS) patients (pts): Preliminary results of the 02-02 Groupe Français de Pneumo-Cancérologie(GFPC) study
Hervé, L., Céline, G., Christos, C., Hervé, J., Jacques, L., Pierre, B., Laurence, G., Stephane, H., Dominique, P., Jean Baptiste, A.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80989-4
Date:
July, 2005
File:
PDF, 131 KB
english, 2005